Código QR (código de barras bidimensional)

Risk factors for the failure of first‐line PARP inhibitor maintenance therapy in patients with advanced ovarian cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA‐3004)

Abstract Objective To identify the risk factors for failure of first‐line poly (ADP‐ribose) polymerase inhibitor (PARPi) maintenance therapy in patients with advanced ovarian cancer. Method Patients with stage III‐IV epithelial ovarian cancer who received first‐line PARPi maintenance therapy were re...

ver descrição completa

Na minha lista:
Principais autores: Nam Kyeong Kim, Yeorae Kim, Hee Seung Kim, Soo Jin Park, Dong Won Hwang, Sung Jong Lee, Ji Geun Yoo, Suk‐Joon Chang, Joo‐Hyuk Son, Tae‐Wook Kong, Jeeyeon Kim, Seung‐Hyuk Shim, A Jin Lee, Dong Hoon Suh, Yoo‐Young Lee
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley 2023-10-01
coleção:Cancer Medicine
Assuntos:
first‐line maintenance therapy
ovarian cancer
poly (ADP‐ribose) polymerase inhibitor
recurrence
risk factor
Acesso em linha:https://doi.org/10.1002/cam4.6546
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados